cagrilintide semaglutide combination cagrisema phase 3 results 2024 2025 Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes Novo Nordisk's CagriSema 2.4 mg

Should I use GLP-1 instead of therapy or psychiatric medication for binge eating disorder

Observed Heart Rate Changes: Increase of 5-10 beats per minute during treatment Peak increase around week 24, then gradual decline Persists but diminishes through week 68 Why This Happens: Sympathetic nervous system activation Increased metabolic rate from weight loss Direct effects on cardiac tissue Clinical Significance: Modest heart rate increases (5-10 bpm) don't appear harmful in clinical trials

Actual delivery time depends on the products ordered and the shipping time of the particular merchant

Your Hunger Returns When you stop the medication, your appetite returns to its previous level, making it harder to eat less